Literature DB >> 33296908

Renal Dysfunction following Direct Current Cardioversion of Atrial Fibrillation: Incidence and Risk Factors.

Nicolai Grüner-Hegge1, Danesh K Kella2, Deepak Padmanabhan2, Abhishek J Deshmukh2, Ramila Mehta3, David Hodge3, Rowlens M Melduni2, Eddie L Greene4, Paul A Friedman5.   

Abstract

INTRODUCTION: Emerging data suggest that cardioversion for atrial fibrillation (AF) may be associated with acute kidney injury (AKI). However, limited data are available regarding the incidence and risk factors for AKI after direct current cardioversion (DCCV) of AF.
METHODS: All patients undergoing DCCV at Mayo Clinic between 2001 and 2012 for AF were prospectively enrolled in a database. All patients with serum creatinine (SCR) values pre- and post-cardioversion were reviewed for AKI, defined as a ≥25% decline in eGFR (estimated glomerular filtration rate) from baseline value within 7 days of the DCCV.
RESULTS: Of the 6,427 eligible patients, 1,256 (19.5%) patients had pre- and post-DCCV SCR available and formed the cohort under study. The mean age was 70.4 (SD 11.7) years, and 67.3% were male. During the study period, 131 (10.4%) patients suffered from AKI following DCCV. AKI was independently associated with inpatient status (OR 26.79; 95% CI 3.69-194.52), CHA2DS2-VASc score (OR 1.25; 95% CI 1.11-1.41), prior use of diuretics (OR 1.59; 95% CI 1.03-2.46), and absence of CKD (OR 1.61; 95% CI 1.04-2.49), and was independent of the success of the DCCV. None of the patients required acute dialysis during the study outcome period.
CONCLUSION: AKI following DCCV of AF is common, self-limited, and without the need for replacement therapies.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Acute kidney injury; Atrial fibrillation; Direct current cardioversion

Mesh:

Year:  2020        PMID: 33296908      PMCID: PMC9097007          DOI: 10.1159/000507566

Source DB:  PubMed          Journal:  Cardiorenal Med        ISSN: 1664-5502            Impact factor:   2.041


  31 in total

1.  A comparison of rate control and rhythm control in patients with atrial fibrillation.

Authors:  D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

2.  Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Usman Baber; Virginia J Howard; Jonathan L Halperin; Elsayed Z Soliman; Xiao Zhang; William McClellan; David G Warnock; Paul Muntner
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-11-13

3.  Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study.

Authors:  S Corrao; C Argano; A Nobili; M Marcucci; C D Djade; M Tettamanti; L Pasina; C Franchi; A Marengoni; F Salerno; F Violi; P M Mannucci; F Perticone
Journal:  Eur J Intern Med       Date:  2015-03-05       Impact factor: 4.487

4.  Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography.

Authors:  R A Grimm; W J Stewart; J D Maloney; G I Cohen; G L Pearce; E E Salcedo; A L Klein
Journal:  J Am Coll Cardiol       Date:  1993-11-01       Impact factor: 24.094

5.  Electrical reversion of cardiac arrhythmias.

Authors:  B Lown
Journal:  Br Heart J       Date:  1967-07

Review 6.  Epidemiology and natural history of atrial fibrillation: clinical implications.

Authors:  S S Chugh; J L Blackshear; W K Shen; S C Hammill; B J Gersh
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

Review 7.  Atrial stunning: basics and clinical considerations.

Authors:  Ijaz A Khan
Journal:  Int J Cardiol       Date:  2003-12       Impact factor: 4.164

Review 8.  The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS.

Authors:  Giuseppina Novo; Daniela Guttilla; Giovanni Fazio; Debbie Cooper; Salvatore Novo
Journal:  Br J Clin Pharmacol       Date:  2008-09       Impact factor: 4.335

9.  Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: the FinCV study.

Authors:  Toni Grönberg; Ilpo Nuotio; Marko Nikkinen; Antti Ylitalo; Tuija Vasankari; Juha E K Hartikainen; K E Juhani Airaksinen
Journal:  Europace       Date:  2013-05-17       Impact factor: 5.214

10.  Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.

Authors:  Giuseppe Boriani; Irina Savelieva; Gheorghe-Andrei Dan; Jean Claude Deharo; Charles Ferro; Carsten W Israel; Deirdre A Lane; Gaetano La Manna; Joseph Morton; Angel Moya Mitjans; Marc A Vos; Mintu P Turakhia; Gregory Y H Lip
Journal:  Europace       Date:  2015-06-24       Impact factor: 5.214

View more
  1 in total

1.  Acute rate control in atrial fibrillation: an urgent need for the clinician.

Authors:  Gheorghe-Andrei Dan; Anca R Dan; Andreea Ivanescu; Adrian C Buzea
Journal:  Eur Heart J Suppl       Date:  2022-06-13       Impact factor: 1.624

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.